REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medimfarma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Chemical and Allied Products Merchant Wholesalers | Pharmacies and Drug Stores | Electronic Shopping and Mail-Order Houses
Full name: Medimfarma S.A.S. Profile Updated: May 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Medimfarma S.A.S. is an enterprise in Colombia, with the main office in Cali. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on August 18, 2021. From the latest financial highlights, Medimfarma S.A.S. reported a net sales revenue increase of 17.17% in 2023. Its’ total assets recorded a growth of 44.73%. In, 2023, the company’s net profit margin decreased by 3.56%.

Headquarters
Cl 5 # 121 B - 56 Ap 302
Cali; Valle del Cauca;

Contact Details: Purchase the Medimfarma S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Medimfarma S.A.S. report to view the information.
Incorporation Date:
August 18, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Medimfarma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
17.17%▲
Total operating revenue
17.17%▲
Operating profit (EBIT)
-58.54%▼
Net Profit (Loss) for the Period
-43.38%▼
Total assets
44.73%▲
Total equity
25.73%▲
Operating Profit Margin (ROS)
-6.1%▼
Net Profit Margin
-3.56%▼
Return on Equity (ROE)
-24.98%▼
Quick Ratio
-0.73%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo